|
2CT7
Solution Structure of the IBR domain of the RING finger protein 31 protein
Deposited 2005-05-23
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
779–851(73 aa)
Fragment:IBR domain
|
Not recorded
|
ZN ZINC ION × 2
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 220;Pressure ambient
NMR sample composition
1.55mM IBR domain U-13C,15N; 20mM d-Tris-HCl; 200mM NaCl; 1mM d-DTT; 0.02% NaN3; 0.01mM ZnCl2; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
4DBG
Crystal structure of HOIL-1L-UBL complexed with a HOIP-UBA derivative
Deposited 2012-01-15
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
480–636(157 aa)
Fragment:Ub-associated domain, residues 480-636
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;15%(w/v) PEG6000, 0.1M KCl, 0.1M HEPES-Na buffer, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K
|
Resolution 2.71 Å
R-free 0.253
|
|
4JUY
Crystal structure of the PUB domain of E3 ubiquitin ligase RNF31
Deposited 2013-03-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
1–180(180 aa)
Chain B
1–180(180 aa)
|
Not recorded
|
UNX UNKNOWN LIGAND × 40
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;291 K;0.8M K/Na tartrate tetrahydrate, 0.5% PEG MME 5000, 0.1 M BisTris, pH 8.5, vapor diffusion, hanging drop, temperature 291K
|
Resolution 2.40 Å
R-free 0.258
|
|
4LJO
Structure of an active ligase (HOIP)/ubiquitin transfer complex
Deposited 2013-07-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
853–1072(220 aa)
Fragment:E3 ligase HOIP catalytic core (unp residues 853-1072)
|
Not recorded
|
ZN ZINC ION × 5
IMD IMIDAZOLE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.5;293 K;0.1 M carboxylic acids, 0.1 M imidazole, MES, 30 % P550 MME_P20K, pH 6.5, vapour diffusion, temperature 293K, VAPOR DIFFUSION
|
Resolution 1.56 Å
R-free 0.212
|
|
4LJP
Structure of an active ligase (HOIP-H889A)/ubiquitin transfer complex
Deposited 2013-07-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
853–1072(220 aa)
Fragment:E3 ligase HOIP catalytic core (unp residues 853-1072)
|
Mutation:H889A
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M amino acids, 0.1 M imidazole, MES, 30 % P550 MME_P20K , pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.15 Å
R-free 0.216
|
|
4LJQ
Crystal structure of the catalytic core of E3 ligase HOIP
Deposited 2013-07-05
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
853–1072(220 aa)
Fragment:Catalytic domain (unp residues 853-1072)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ZN ZINC ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.45 Å
R-free 0.243
|
|
4LJQ
Crystal structure of the catalytic core of E3 ligase HOIP
Deposited 2013-07-05
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
853–1072(220 aa)
Fragment:Catalytic domain (unp residues 853-1072)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ZN ZINC ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.45 Å
R-free 0.243
|
|
4LJQ
Crystal structure of the catalytic core of E3 ligase HOIP
Deposited 2013-07-05
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
853–1072(220 aa)
Fragment:Catalytic domain (unp residues 853-1072)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.45 Å
R-free 0.243
|
|
4LJQ
Crystal structure of the catalytic core of E3 ligase HOIP
Deposited 2013-07-05
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
853–1072(220 aa)
Fragment:Catalytic domain (unp residues 853-1072)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.45 Å
R-free 0.243
|
|
4LJQ
Crystal structure of the catalytic core of E3 ligase HOIP
Deposited 2013-07-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
853–1072(220 aa)
Fragment:Catalytic domain (unp residues 853-1072)
Chain C
853–1072(220 aa)
Fragment:Catalytic domain (unp residues 853-1072)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ZN ZINC ION × 9
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.45 Å
R-free 0.243
|
|
4LJQ
Crystal structure of the catalytic core of E3 ligase HOIP
Deposited 2013-07-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
853–1072(220 aa)
Fragment:Catalytic domain (unp residues 853-1072)
Chain D
853–1072(220 aa)
Fragment:Catalytic domain (unp residues 853-1072)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ZN ZINC ION × 9
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.45 Å
R-free 0.243
|
|
4OWF
Crystal structure of the NEMO CoZi in complex with HOIP NZF1 domain
Deposited 2014-01-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain G
199–228(30 aa)
|
Not recorded
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;Co-crystals were obtained after 6 days in 20% (w/v) PEG-3350 and 0.2 M DL-malic acid
|
Resolution 2.00 Å
R-free 0.313
|
|
4OYK
Structure of HOIP PUB domain bound to OTULIN PIM
Deposited 2014-02-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
3–179(177 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.4;295 K;32% PEG 6000, 1M LiCl, 100 mM Tris pH 8.4
|
Resolution 2.00 Å
R-free 0.237
|
|
4OYK
Structure of HOIP PUB domain bound to OTULIN PIM
Deposited 2014-02-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
3–179(177 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.4;295 K;32% PEG 6000, 1M LiCl, 100 mM Tris pH 8.4
|
Resolution 2.00 Å
R-free 0.237
|
|
4P09
Crystal structure of HOIP PUB domain
Deposited 2014-02-20
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–179(179 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0,1M Tris, 20% 2-methyl-2,4-pentanediol, 15% Polyethyleneglycol 3350, pH 8.5
|
Resolution 1.70 Å
R-free 0.230
|
|
4P0A
Crystal structure of HOIP PUB domain in complex with p97 PIM
Deposited 2014-02-20
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–179(179 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0,1M Tris, 20% 2-methyl-2,4-pentanediol, 15% Polyethyleneglycol 3350, pH 6.5
|
Resolution 2.30 Å
R-free 0.249
|
|
4P0A
Crystal structure of HOIP PUB domain in complex with p97 PIM
Deposited 2014-02-20
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–179(179 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0,1M Tris, 20% 2-methyl-2,4-pentanediol, 15% Polyethyleneglycol 3350, pH 6.5
|
Resolution 2.30 Å
R-free 0.249
|
|
4P0B
Crystal structure of HOIP PUB domain in complex with OTULIN PIM
Deposited 2014-02-20
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–179(179 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;0,1M Tris, 20% 2-methyl-2,4-pentanediol, 15% Polyethyleneglycol 3350, pH 7.5
|
Resolution 2.70 Å
R-free 0.270
|
|
4P0B
Crystal structure of HOIP PUB domain in complex with OTULIN PIM
Deposited 2014-02-20
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–179(179 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;0,1M Tris, 20% 2-methyl-2,4-pentanediol, 15% Polyethyleneglycol 3350, pH 7.5
|
Resolution 2.70 Å
R-free 0.270
|
|
5EDV
Structure of the HOIP-RBR/UbcH5B~ubiquitin transfer complex
Deposited 2015-10-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
696–1072(377 aa)
Fragment:UNP residues 696-1072
|
Not recorded
|
ZN ZINC ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;285 K;0.06M Tris, 0.04M Bicine, 0.02 M 1,6-Hexanediol, 0.02 M 1-Butanol, 0.02 M 1,2-
Propanediol (racemic), 0.02 M 2-Propanol, 0.02 M 1,4-Butanediol, 0.02 M 1,3-Propanediol, 20% PEG550MME, 10% PEG20K, 8% glycerol
|
Resolution 3.48 Å
R-free 0.303
|
|
5EDV
Structure of the HOIP-RBR/UbcH5B~ubiquitin transfer complex
Deposited 2015-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain A
696–1072(377 aa)
Fragment:UNP residues 696-1072
Chain B
696–1072(377 aa)
Fragment:UNP residues 696-1072
|
Not recorded
|
ZN ZINC ION × 16
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;285 K;0.06M Tris, 0.04M Bicine, 0.02 M 1,6-Hexanediol, 0.02 M 1-Butanol, 0.02 M 1,2-
Propanediol (racemic), 0.02 M 2-Propanol, 0.02 M 1,4-Butanediol, 0.02 M 1,3-Propanediol, 20% PEG550MME, 10% PEG20K, 8% glycerol
|
Resolution 3.48 Å
R-free 0.303
|
|
5EDV
Structure of the HOIP-RBR/UbcH5B~ubiquitin transfer complex
Deposited 2015-10-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
696–1072(377 aa)
Fragment:UNP residues 696-1072
|
Not recorded
|
ZN ZINC ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;285 K;0.06M Tris, 0.04M Bicine, 0.02 M 1,6-Hexanediol, 0.02 M 1-Butanol, 0.02 M 1,2-
Propanediol (racemic), 0.02 M 2-Propanol, 0.02 M 1,4-Butanediol, 0.02 M 1,3-Propanediol, 20% PEG550MME, 10% PEG20K, 8% glycerol
|
Resolution 3.48 Å
R-free 0.303
|
|
5LJN
Structure of the HOIP PUB domain bound to SPATA2 PIM peptide
Deposited 2016-07-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
5–176(172 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;1.7-1.9 M (NH4)2SO4, 50 mM sodium cacodylate pH 6.4-7.0, 15 mM MgCl2
Protein:precipitant ratio; 1:2
200 nl drops
|
Resolution 2.70 Å
R-free 0.281
|
|
5LJN
Structure of the HOIP PUB domain bound to SPATA2 PIM peptide
Deposited 2016-07-18
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
5–176(172 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;1.7-1.9 M (NH4)2SO4, 50 mM sodium cacodylate pH 6.4-7.0, 15 mM MgCl2
Protein:precipitant ratio; 1:2
200 nl drops
|
Resolution 2.70 Å
R-free 0.281
|
|
5X0W
Molecular mechanism for the binding between Sharpin and HOIP
Deposited 2017-01-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
480–639(160 aa)
Fragment:UNP residues 480-639
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.3;289 K;0.1 M HEPES (pH 7.3), 7% (w/v) PEG8000, 8% (v/v) ethylene glycerol
|
Resolution 3.00 Å
R-free 0.302
|
|
5X0W
Molecular mechanism for the binding between Sharpin and HOIP
Deposited 2017-01-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
480–639(160 aa)
Fragment:UNP residues 480-639
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.3;289 K;0.1 M HEPES (pH 7.3), 7% (w/v) PEG8000, 8% (v/v) ethylene glycerol
|
Resolution 3.00 Å
R-free 0.302
|
|
5X0W
Molecular mechanism for the binding between Sharpin and HOIP
Deposited 2017-01-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
480–639(160 aa)
Fragment:UNP residues 480-639
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.3;289 K;0.1 M HEPES (pH 7.3), 7% (w/v) PEG8000, 8% (v/v) ethylene glycerol
|
Resolution 3.00 Å
R-free 0.302
|
|
5X0W
Molecular mechanism for the binding between Sharpin and HOIP
Deposited 2017-01-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain G
480–639(160 aa)
Fragment:UNP residues 480-639
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.3;289 K;0.1 M HEPES (pH 7.3), 7% (w/v) PEG8000, 8% (v/v) ethylene glycerol
|
Resolution 3.00 Å
R-free 0.302
|
|
6GZY
HOIP-fragment5 complex
Deposited 2018-07-05
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
853–1072(220 aa)
|
Not recorded
|
FHH methyl 4-[(2-oxidanylidene-1,5,6,7-tetrahydrocyclopenta[b]pyridin-3-yl)carbonylamino]butanoate × 1
ZN ZINC ION × 4
SO4 SULFATE ION × 4
EDO 1,2-ETHANEDIOL × 2
PGE TRIETHYLENE GLYCOL × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;0.1 M Tris HCl pH 8.5, 28% w/v PEG 4000, 0.2 M Li2SO4
|
Resolution 2.15 Å
R-free 0.246
|
|
6GZY
HOIP-fragment5 complex
Deposited 2018-07-05
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
853–1072(220 aa)
|
Not recorded
|
FHH methyl 4-[(2-oxidanylidene-1,5,6,7-tetrahydrocyclopenta[b]pyridin-3-yl)carbonylamino]butanoate × 1
ZN ZINC ION × 4
SO4 SULFATE ION × 3
EDO 1,2-ETHANEDIOL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;0.1 M Tris HCl pH 8.5, 28% w/v PEG 4000, 0.2 M Li2SO4
|
Resolution 2.15 Å
R-free 0.246
|
|
6KC5
HOIP-HOIPIN1 complex
Deposited 2019-06-27
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
853–1072(220 aa)
|
Not recorded
|
ZN ZINC ION × 4
D5U 2-[3-(2-methoxyphenyl)-3-oxidanylidene-propyl]benzoic acid × 1
GOL GLYCEROL × 4
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;100 mM HEPES-Na (pH 7.5), 200 mM NaCl, 25% PEG 3,350
|
Resolution 1.54 Å
R-free 0.217
|
|
6KC6
HOIP-HOIPIN8 complex
Deposited 2019-06-27
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
853–1072(220 aa)
|
Not recorded
|
ZN ZINC ION × 4
D60 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1
CL CHLORIDE ION × 3
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;200 mM KCl, 20% PEG3,350
|
Resolution 2.12 Å
R-free 0.267
|
|
6KC6
HOIP-HOIPIN8 complex
Deposited 2019-06-27
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
853–1072(220 aa)
|
Not recorded
|
ZN ZINC ION × 4
D60 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1
CL CHLORIDE ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;200 mM KCl, 20% PEG3,350
|
Resolution 2.12 Å
R-free 0.267
|
|
6KC6
HOIP-HOIPIN8 complex
Deposited 2019-06-27
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain E
853–1072(220 aa)
|
Not recorded
|
ZN ZINC ION × 4
D60 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1
CL CHLORIDE ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;200 mM KCl, 20% PEG3,350
|
Resolution 2.12 Å
R-free 0.267
|
|
6KC6
HOIP-HOIPIN8 complex
Deposited 2019-06-27
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain G
853–1072(220 aa)
|
Not recorded
|
ZN ZINC ION × 4
D60 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1
CL CHLORIDE ION × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;200 mM KCl, 20% PEG3,350
|
Resolution 2.12 Å
R-free 0.267
|
|
6KC6
HOIP-HOIPIN8 complex
Deposited 2019-06-27
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain I
853–1072(220 aa)
|
Not recorded
|
ZN ZINC ION × 4
D60 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;200 mM KCl, 20% PEG3,350
|
Resolution 2.12 Å
R-free 0.267
|
|
6KC6
HOIP-HOIPIN8 complex
Deposited 2019-06-27
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain K
853–1072(220 aa)
|
Not recorded
|
ZN ZINC ION × 4
D60 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1
CL CHLORIDE ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;200 mM KCl, 20% PEG3,350
|
Resolution 2.12 Å
R-free 0.267
|
|
6SC5
dAb3/HOIP-RBR-Ligand2
Deposited 2019-07-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
697–1072(376 aa)
|
Not recorded
|
L6B methyl 4-[(2-oxidanylidene-5,6,7,8-tetrahydro-1~{H}-quinolin-3-yl)carbonylamino]but-3-enoate × 1
ZN ZINC ION × 8
SO4 SULFATE ION × 4
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium chloride, HEPES
|
Resolution 2.10 Å
R-free 0.252
|
|
6SC6
dAb3/HOIP-RBR apo structure
Deposited 2019-07-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
697–1072(376 aa)
|
Not recorded
|
ZN ZINC ION × 8
SO4 SULFATE ION × 5
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium chloride, HEPES
|
Resolution 2.25 Å
R-free 0.246
|
|
6SC7
dAb3/HOIP-RBR-Ligand3
Deposited 2019-07-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
697–1072(376 aa)
|
Not recorded
|
L6H [2-[3-(cyclooct-4-en-1-yloxycarbonylamino)propylamino]-2-oxidanylidene-ethyl] (~{E})-4-[(2-oxidanylidene-5,6,7,8-tetrahydro-1~{H}-quinolin-3-yl)carbonylamino]but-2-enoate × 1
ZN ZINC ION × 8
SO4 SULFATE ION × 4
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium chloride, HEPES
|
Resolution 2.56 Å
R-free 0.267
|
|
6SC8
dAb3/HOIP-RBR-Ligand4
Deposited 2019-07-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
697–1072(376 aa)
|
Not recorded
|
L6E [2-(methylamino)-2-oxidanylidene-ethyl] (~{E})-4-[(2-oxidanylidene-5,6,7,8-tetrahydro-1~{H}-quinolin-3-yl)carbonylamino]but-2-enoate × 1
ZN ZINC ION × 8
SO4 SULFATE ION × 3
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium chloride, HEPES
|
Resolution 2.11 Å
R-free 0.261
|
|
6SC9
dAb3/HOIP-RBR-HOIPIN-8
Deposited 2019-07-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
697–1072(376 aa)
|
Not recorded
|
L68 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-prop-1-enyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1
ZN ZINC ION × 8
SO4 SULFATE ION × 2
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium chloride, HEPES
|
Resolution 2.47 Å
R-free 0.252
|
|
7TV4
Crystal structure of NEMO CoZi in complex with HOIP NZF1 and linear diubiquitin
Deposited 2022-02-03
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain K
350–379(30 aa)
Fragment:Residues 350-379
|
Not recorded
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.1 M Tris-HCl, pH 8.5, 22% v/v PEG Smear Broad
|
Resolution 4.20 Å
R-free 0.286
|
|
7UY2
Structure of RNF31 in complex with FP06649, a Helicon Polypeptide
Deposited 2022-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–179(179 aa)
|
Not recorded
|
NH2 AMINO GROUP × 1
WHL N,N'-(1,4-phenylene)diacetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.06 M Divalents (0.3M Magnesium chloride hexahydrate; 0.3M Calcium chloride dihydrate), 0.1 M Buffer System 1 (Imidazole; MES monohydrate (acid) pH 6.5), 37.5% Precipitant Mix 4 (25% v/v MPD; 25% PEG 1000; 25% w/v PEG 3350)
|
Resolution 2.51 Å
R-free 0.270
|
|
7UY2
Structure of RNF31 in complex with FP06649, a Helicon Polypeptide
Deposited 2022-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–179(179 aa)
|
Not recorded
|
NH2 AMINO GROUP × 1
WHL N,N'-(1,4-phenylene)diacetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.06 M Divalents (0.3M Magnesium chloride hexahydrate; 0.3M Calcium chloride dihydrate), 0.1 M Buffer System 1 (Imidazole; MES monohydrate (acid) pH 6.5), 37.5% Precipitant Mix 4 (25% v/v MPD; 25% PEG 1000; 25% w/v PEG 3350)
|
Resolution 2.51 Å
R-free 0.270
|
|
7UYJ
Structure of RNF31 in complex with FP06652, a Helicon Polypeptide
Deposited 2022-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–179(179 aa)
|
Not recorded
|
NH2 AMINO GROUP × 1
WHL N,N'-(1,4-phenylene)diacetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.1 M Amino Acids (0.2M DL-Glutamic acid monohydrate; 0.2M DL-Alanine; 0.2M Glycine; 0.2M DL-Lysine monohydrochloride; 0.2M DL-Serine),0.1 M Buffer System 1 (Imidazole; MES monohydrate (acid) pH 6.5), 30.0% Precipitant Mix 1 (40% v/v PEG 500* MME; 20 % w/v PEG 20000)
|
Resolution 2.32 Å
R-free 0.274
|
|
7UYJ
Structure of RNF31 in complex with FP06652, a Helicon Polypeptide
Deposited 2022-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–179(179 aa)
|
Not recorded
|
NH2 AMINO GROUP × 1
WHL N,N'-(1,4-phenylene)diacetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.1 M Amino Acids (0.2M DL-Glutamic acid monohydrate; 0.2M DL-Alanine; 0.2M Glycine; 0.2M DL-Lysine monohydrochloride; 0.2M DL-Serine),0.1 M Buffer System 1 (Imidazole; MES monohydrate (acid) pH 6.5), 30.0% Precipitant Mix 1 (40% v/v PEG 500* MME; 20 % w/v PEG 20000)
|
Resolution 2.32 Å
R-free 0.274
|
|
7UYK
Structure of RNF31 in complex with FP06655, a Helicon Polypeptide
Deposited 2022-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
480–639(160 aa)
|
Not recorded
|
NH2 AMINO GROUP × 1
WHL N,N'-(1,4-phenylene)diacetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;10% w/v glycerol, 20% w/v ethanol
|
Resolution 2.70 Å
R-free 0.245
|
|
7UYK
Structure of RNF31 in complex with FP06655, a Helicon Polypeptide
Deposited 2022-05-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
480–639(160 aa)
|
Not recorded
|
NH2 AMINO GROUP × 1
WHL N,N'-(1,4-phenylene)diacetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;10% w/v glycerol, 20% w/v ethanol
|
Resolution 2.70 Å
R-free 0.245
|
|
7V8F
Crystal structure of UBE2L3 bound to HOIP RING1 domain.
Deposited 2021-08-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
697–793(97 aa)
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 8;289 K;2%(v/v) 1,4-dioxane, 0.1 M Tris-HCl (pH 8.0), 15%(w/v) PEG 3,350.
|
Resolution 1.66 Å
R-free 0.198
|
|
7V8G
Crystal structure of HOIP RING1 domain bound to IpaH1.4 LRR domain
Deposited 2021-08-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
697–793(97 aa)
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 8;289 K;2%(v/v) 1,4-dioxane, 0.1 M Tris-HCl (pH 8.0), 15%(v/v) PEG 3,350
|
Resolution 2.75 Å
R-free 0.278
|
|
7V8G
Crystal structure of HOIP RING1 domain bound to IpaH1.4 LRR domain
Deposited 2021-08-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
697–793(97 aa)
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 8;289 K;2%(v/v) 1,4-dioxane, 0.1 M Tris-HCl (pH 8.0), 15%(v/v) PEG 3,350
|
Resolution 2.75 Å
R-free 0.278
|
|
8Z30
Crystal structure of HOIP PUB domain in complex with tolfenamic acid complex
Deposited 2024-04-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
4–179(176 aa)
Chain B
4–179(176 aa)
Chain C
4–179(176 aa)
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 3
TLF 2-[(3-chloro-2-methylphenyl)amino]benzoic acid × 3
PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1
TOE 2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXYL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;20 mM Tris, 150 mM NaCl, pH 7.5, 10% w/v PEG1000, 10% w/v PEG8000
|
Resolution 2.30 Å
R-free 0.242
|
|
8Z36
Crystal structure of HOIP PUB domain in complex with sertraline complex
Deposited 2024-04-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
4–179(176 aa)
Chain B
4–179(176 aa)
Chain C
4–179(176 aa)
|
Not recorded
|
SRE (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;20 mM Na3PO4, 20 mM K3PO4, pH 7.5, 20% PEG 3350
|
Resolution 2.63 Å
R-free 0.269
|
|
9AZJ
Structure of ubiquitinated NEMO UBAN K285C-Ub G76C bound to HOIP NZF1
Deposited 2024-03-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain E
351–379(29 aa)
Fragment:HOIP NZF domain, residues 351-379
Chain G
351–379(29 aa)
Fragment:HOIP NZF domain, residues 351-379
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8.6;293 K;150nl protein + 50 nl mother liquor: 0.1 M Tris/Bicine pH 8.6, 24.2% PEG 500 MME, 8% PEG 20K, 0.03 M each of NaI, NaBr, and NaF. Cryoprotected in mother liquor containing 20% glycerol
|
Resolution 3.32 Å
R-free 0.285
|
|
9B0B
Structure of Optineurin bound to HOIP NZF1 domain
Deposited 2024-03-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain G
350–379(30 aa)
|
Not recorded
|
PGE TRIETHYLENE GLYCOL × 5
PG4 TETRAETHYLENE GLYCOL × 1
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8.5;293 K;3:1 (protein:mother liquor: 10% PEG 8K, 20% ethylene glycol, 0.1 M Tris/Bicine pH 8.5, 0.03 M MgCl2 and 0.03 M CaCl2. cryoprotected in mother liquor containing 10% glycerol
|
Resolution 1.70 Å
R-free 0.222
|
|
9B0B
Structure of Optineurin bound to HOIP NZF1 domain
Deposited 2024-03-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
350–379(30 aa)
|
Not recorded
|
PGE TRIETHYLENE GLYCOL × 5
PG4 TETRAETHYLENE GLYCOL × 1
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8.5;293 K;3:1 (protein:mother liquor: 10% PEG 8K, 20% ethylene glycol, 0.1 M Tris/Bicine pH 8.5, 0.03 M MgCl2 and 0.03 M CaCl2. cryoprotected in mother liquor containing 10% glycerol
|
Resolution 1.70 Å
R-free 0.222
|
|
9B0Z
Structure of Optineurin bound to HOIP NZF1 domain and M1-linked diubiquitin, crystal form 2
Deposited 2024-03-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain E
350–379(30 aa)
Chain F
350–379(30 aa)
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8.5;293 K;20% PEG 2K MME, 0.2 M TAO and 0.1 M Tris pH 8.5. Cryoprotected in mother liquor containing 20% glycerol
|
Resolution 2.41 Å
R-free 0.270
|
|
9B12
Structure of Optineurin bound to HOIP NZF1 domain and M1-linked diubiquitin, crystal form 1
Deposited 2024-03-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain G
350–379(30 aa)
Chain H
350–379(30 aa)
|
Not recorded
|
PG4 TETRAETHYLENE GLYCOL × 1
PGE TRIETHYLENE GLYCOL × 1
CL CHLORIDE ION × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;293 K;3:1 with reservoir solution containing 50% PEG 200 and 0.1 M HEPES pH 7.5
|
Resolution 1.81 Å
R-free 0.269
|
|
9B12
Structure of Optineurin bound to HOIP NZF1 domain and M1-linked diubiquitin, crystal form 1
Deposited 2024-03-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain I
350–379(30 aa)
Chain J
350–379(30 aa)
|
Not recorded
|
PG4 TETRAETHYLENE GLYCOL × 1
CL CHLORIDE ION × 2
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 3
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;293 K;3:1 with reservoir solution containing 50% PEG 200 and 0.1 M HEPES pH 7.5
|
Resolution 1.81 Å
R-free 0.269
|
|
9IIC
Crystal structure of HOIP RING2-LDD in complex with STK4 KD domain
Deposited 2024-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
857–1071(215 aa)
Fragment:RING2-LDD
|
Not recorded
|
GOL GLYCEROL × 1
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.2 M Ammonium citrate tribasic (pH 7.0), 20% w/v Polyethylene glycol 3350
|
Resolution 2.78 Å
R-free 0.280
|
|
9IIC
Crystal structure of HOIP RING2-LDD in complex with STK4 KD domain
Deposited 2024-06-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
857–1071(215 aa)
Fragment:RING2-LDD
|
Not recorded
|
GOL GLYCEROL × 1
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.2 M Ammonium citrate tribasic (pH 7.0), 20% w/v Polyethylene glycol 3350
|
Resolution 2.78 Å
R-free 0.280
|